Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Use of Prebiotics, Probiotics and Synbiotics in Clinical Immunonutrition

  • Published : 2002.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

It is a recent observation that about 80 per cent of the body's immune system is localized in the gastrointestinal tract. This explains to a large extent why eating right is important for the modulation the immune response and prevention of disease. In addition it is increasingly recognized that the body has an important digestive system also in the lower gastrointestinal tract where numerous important substances are released by microbial enzymes and absorbed. Among these substances are short chain fatty acids, amino acids, various carbohydrates, poly-amines, growth factors, coagulation factors, and many thousands of antioxidants, not only traditional vitamins but numerous flavonoids, carotenoids and similar plant- and vegetable produced antioxidants. Also consumption of health-promoting bacteria (probiotics) and vegetable fibres (prebiotics) from numerous sources are known to have strong health-promoting influence. It has been calculated that the intestine harbours about 300,000 genes, which is much more than the calculated about 60,000 for the rest of the human body, indicating a till today totally unexpected metabolic activity in this part of the GI tract. There are seemingly several times more active enzymes in the intestine than in the rest of the body, ready to release hundred thousand or more of substances important for our health and well-being. In addition do the microbial cells produce signal molecules similar to cytokines but called bacteriokines and nitric oxide, with provide modulatory effects both on the mucosal cells, the mucosa- associated lymphoid system (MALT) and the rest of the immune system. Identification of various fermentation products, and often referred to as synbiotics, studies of their role in maintaining health and well-being should be a priority issue during the years to come.

Keywords

References

  1. Eaton SB, Konnor M. 1985. Paleolithic nutrition. A consideration of its nature and current implications. New Engl J Med 312: 283-289 https://doi.org/10.1056/NEJM198501313120505
  2. Aisen PS, Davis KL. 1994. Inflammatory mechanisms in Alz-heimer: Implications for therapy. Am J Psychiat 151: 1105-1113 https://doi.org/10.1176/ajp.151.8.1105
  3. Diplock AT, Charleux JI, Crozier-Willi G. 1998. Functional food science and defence against oxidative species. Br J Nutr 80: Suppl 1: S77-112 https://doi.org/10.1079/BJN19980106
  4. Bengmark S. 2001. Nutritional modulation of acute and “chronic” phase response. Nutrition 17: 489-495 https://doi.org/10.1016/S0899-9007(01)00581-0
  5. Maes M. 1995. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19: 11-38 https://doi.org/10.1016/0278-5846(94)00101-M
  6. Adlerberth I, Carlsson B, deMan P. 1991. Intestinal coloni-zation with Enterobacteriaceae in Parkistani and Swedish hospital-delivered infants. Acta Pediatr Scand 80: 602-610 https://doi.org/10.1111/j.1651-2227.1991.tb11917.x
  7. Ahrn S, Nobaek S, Jeppsson B. 1998. The normal Lactoba-cillus flora in healthy human rectal and oral mucosa. J Appl Microbiol 85: 88-94 https://doi.org/10.1046/j.1365-2672.1998.00480.x
  8. Lencner AA, Lencner CP, Mikelsaar ME. 1983. Die quantitative Zusammensetzung der Lactoflora des Verdauung-strakts vor und nach kosmischen Flgen unterschiedlicher Dauer. Die Nahrung 28: 607-613
  9. Andersson R, Wang X, Ihse I. 1995. The influence of abdo-minal sepsis on acute pancreatitis in rats: A study on mor-tality, permeability, arterial blood pressure and intestinal blood flow. Pancreas 11: 365-373 https://doi.org/10.1097/00006676-199511000-00008
  10. Leveau P, Wang X, Soltesz V. 1996. Alterations in intestinal permeability and microflora in experimental acute pancreatitis. Int J Pancrea-tology 20: 119-125
  11. De Souza LJ, Sampietre SN, Figueiredo S. 1996. Bacterial translocation during acute pancreatitis in rats. (In Portuguese, with English summary) Rev Hosp Clin Fac Med S Paolo 51: 116-120
  12. Bengmark S. 1998. Ecological control of the gastrointestinal tract. The role of probiotic bacteria. Gut 42: 2-7 https://doi.org/10.1136/gut.42.1.2
  13. Bengmark S. 1998. Ecoimmunonutrition: A challenge for the third millenium. Nutrition 14: 563-572 https://doi.org/10.1016/S0899-9007(98)00003-3
  14. Bengmark S. 1998. Immunonutrition: Role of biosurfactants, fiber and probiotic bacteria. Nutrition 14: 585-594 https://doi.org/10.1016/S0899-9007(98)00030-6
  15. Bengmark S. 2000. Gut and the immune system: Enteral nutrition and immunonutrients. In SIRS, MODS and MOF­-systemic inflammatory response syndrome, multiple organ dysfunction syndrome, multiple organ failure-pathophysiology, prevention and therapy. Baue AE, Faist E, Fry D, eds. Springer, New York. p 408-424
  16. Bengmark S. 2000. Refunctionalization of the gut. In SIRS, MODS and MOF -­systemic inflammatory response syndrome, multiple organ dysfunction syndrome, multiple organ failure­ - pathophysiology, prevention and therapy. Baue AE, Faist E, Fry D, eds. Springer, New York. p 435-446
  17. Bengmark S. 2000. Prospect for a new and rediscovered form of therapy: Probiotic and phage. In Fighting infection in the 21st century. Andrew PW, Oystron P, Smith GL, Stewart DE, eds. Blackwells. p 97-132
  18. Bengmark S. 2000. Bacteria for optimal health. Nutrition 16: 611-615 https://doi.org/10.1016/S0899-9007(00)00342-7
  19. Bengmark S. Pre-, pro-, and synbiotics. Current Opinion in Clinical Nutrition and Metabolic Care. Under publication
  20. Bengmark S. 2002. Use of Pro-, Pre- and Synbiotics in the ICU­Future options. In Nutritional Considerations in the Intensive Care Unit­Science, Rationale and Practice. Shikora SA, Martindale RG, Schwaitzberg SD, eds. Aspen. Under publication
  21. WHO Scientific Working Group on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents. World Health Organisation; Bacterial, Viral Diseases and Immunology, Geneva WHO/CDS/BVI/95.7
  22. Key FB, Mathers JC. 1995. Digestive adaptations of rats given white bread and cooked haricot beans (Phaseolus vulgaris): large bowel fermentation and digestion of complexes carbohydrates. Brit J Nutr 74: 393-406 https://doi.org/10.1079/BJN19950143
  23. Finegold SM, Sutter VL, Mathisen GE. 1983. Normal indigenous intestinal flora. In Human intestinal microflora in health and disease. Hentges DJ. ed. Academic Press, London. p 3-31
  24. Adlerberth I, Carlsson B, deMan P. 1991. Intestinal colonization with Enterobacteriaceae in Parkistani and Swedish hospital-delivered infants. Acta Pediatr Scand 80: 602-610 https://doi.org/10.1111/j.1651-2227.1991.tb11917.x
  25. Tannock, GW. 1997. Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R and D. Trends in Biotechnology 15: 270-274 https://doi.org/10.1016/S0167-7799(97)01056-1
  26. Van Thiel DH, Finkel R, Friedlander L. 1992. The association of IgA deficiency but not IgG or IgM deficiency with a reduced patient and graft survival following liver transplantation. Transplantation 54: 269-273 https://doi.org/10.1097/00007890-199208000-00015
  27. Brandtzaeg P. 1995. Molecular and cellular aspects of the secretory immunoglobulin system. 103: 1-19
  28. Yasui H, Nagaoka N, Mike A. 1992. Detection of Bifidobacterium strains that induce large quantities of IgA. Micr Ecol Health Dis 5: 155-162 https://doi.org/10.3109/08910609209141310
  29. Solis-Pereyra B, Aattouri N, Lemonnier D. 1997. Role of food in the stimulation of cytokine production. Am J Clin Nutr 66: S521-S525
  30. Lucey DR, Clerici M, Shearer GM. 1996. Type 1 and type 2 cytokine dysregulation in human infections, neoplastic and inflammatory diseases. Clinical Microbiological Review 9: 532-562
  31. Bjrksten B. 1994. Risk factors in early childhood for the development of atopic diseases. Allergy 49: 400-407 https://doi.org/10.1111/j.1398-9995.1994.tb00831.x
  32. Miettinen M, Matikainen S, Vuopio-Varkila J. 1998. Lactobacilli and Streptococci induce Interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66: 6058-6060
  33. Murosaki S, Yamamoto Y, Ito K. 1998. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen- specific IgE production by stimulation of IL-12 production in mice. J Allerg Clin Immunol 102: 57-64 https://doi.org/10.1016/S0091-6749(98)70055-7
  34. Shida K, Makino K, Takamizawa K. 1998. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Internat Arch Allerg Immunol 115: 278-287 https://doi.org/10.1159/000069458
  35. Lin BF, Huang CC, Chiang BL, Jeng SJ. 1996. Dietary fat influences Ia antigen expression, cytokines and prostaglandin E2 production in immune cells in autoimmune-prone NZBxNZW F1 mice. Brit J Nutr 75: 711-722 https://doi.org/10.1079/BJN19960175
  36. Kato I, Yokokura T, Mutai M. 1988. Correlation between increase in Ia-bearing macrophages and induction of T-cell- dependent antitumor activity by Lactobacillus casei in mice. Cancer, Immunol Immunother 26: 215-221
  37. Marin ML, Tejada-Simon MV, Lee JH. 1998. Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparioson with Bifidobacterium sp. and Lactobacillus bulgaricus. J Food Protect 61: 859-864 https://doi.org/10.4315/0362-028X-61.7.859
  38. Heerdt BG, Houston MA, Augenlicht LH. 1994. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Research 54: 3288-3294
  39. Reddy BS. 1998. Prevention of colonic cancer by pre- and probiotics: evidence from laboratory studies. Br J Nutr 89: Suppl 2: S219-S223 https://doi.org/10.1079/BJN2002765
  40. Frame LT, Hart RW, Leakey EA. 1998. Caloric restriction as a mechanism mediating resistance to environmental disease. Environ Health Perspect 106: suppl 1: 313-324 https://doi.org/10.1289/ehp.98106s1313
  41. Malhotra SL. 1968. Studies in blood coagulation, diet and ischemic heart disease in two population groups in India. Brit Heart J 30: 303-308 https://doi.org/10.1136/hrt.30.3.303
  42. Shirabe K, Matsumata T, Shimada M. 1997. A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection-- the results of a randomized prospective study. Hepato-Gastr 44: 205-209
  43. Windsor ACJ, Kanwar S, Li A. 1998. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response, and improves disease severity in acute pancreatitis. Gut 42: 431-435 https://doi.org/10.1136/gut.42.3.431
  44. Heyman M. 2000. Effect of lactic acid bacteria on diarrheal diseases. J Am Coll Nutr 19: S137-S146 https://doi.org/10.1080/07315724.2000.10718084
  45. De Roos NM, Katan MB. 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 71: 405-411
  46. Hove H, Borgaard H, Brobech Mortensen PB. 1999. Lactic acid bacteria and human gastrointestinal tract. Eur J Clin Nutr 53: 339-350 https://doi.org/10.1038/sj.ejcn.1600773
  47. Reid G. 2000. Probiotics in the treatment of diarrheal diseases. Current Infectious Disease Report 2: 78-83 https://doi.org/10.1007/s11908-000-0092-y
  48. Guandalini S, Pensabene L, Zikri MA. 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European study. J Pediatr Gastr Nutr 30: 54-60 https://doi.org/10.1097/00005176-200001000-00018
  49. Oberhelman RA, Gilman RH, Sheen P. 1999. A placebo- controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 134:15-20 https://doi.org/10.1016/S0022-3476(99)70366-5
  50. Du Pont HL. 1999. Prevention of diarrhea by the probiotic Lactobacillus GG. J Pediatr 134: 1-2 https://doi.org/10.1016/S0022-3476(99)70360-4
  51. Hoyos AB. 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3: 197-202 https://doi.org/10.1016/S1201-9712(99)90024-3
  52. Rabbini GH, Teka T, Zaman B. 2001. Clinical studies in persistant diarrhea: dietary management with green banana or pectin in Bangladesh children. Gastroenterology 121: 554- 560 https://doi.org/10.1053/gast.2001.27178
  53. Bartlett JG. 1992. Antibiotic-associated diarrhea. Clin Infect Dis 15: 573-81 https://doi.org/10.1093/clind/15.4.573
  54. Elstner CL, Lindsay AN, Book LS. 1983. Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children. Pediatr Infect Dis 2: 364-366 https://doi.org/10.1097/00006454-198309000-00006
  55. Vanderhoof JA, Whitney DB, Antonson DL. 1999. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135: 564-568 https://doi.org/10.1016/S0022-3476(99)70053-3
  56. Saavendra JM. 1999. Probiotics plus antibiotics; regulating our bacterial environment. J Pediatr 135: 535-537 https://doi.org/10.1016/S0022-3476(99)70046-6
  57. Fabia R, Ar'Rajab A, Johansson ML. 1993. Impairment of bacterial flora in human ulcerative colitis and in experimental colitis in the rat. Digestion 54: 248-255 https://doi.org/10.1159/000201045
  58. Fabia R, Ar'Rajab A, Johansson ML. 1993. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fibre on acetic acid-induced colitis in the rat. Scand J Gastroenterol 28: 155-162 https://doi.org/10.3109/00365529309096063
  59. Favier C, Neut C, Mizon C. 1997. Fecal $\beta$-D-galactosidase and bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 42: 817-822 https://doi.org/10.1023/A:1018876400528
  60. Sartor RB. 1999. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In Inflammatory bowel diseases. 5th ed. Kirsner JG, ed. Saunders, Philadelphia. p 153-178
  61. Pathmakanthan S, Thornley JP, Hawkey CJ. 1999. Mucosally associated bacteria flora of the human colon: quantitative and species specific differences between normal and inflamed colonic biopsies. Microb Ecolog Health Dis 11: 169-174 https://doi.org/10.1080/089106099435754
  62. Venturi A, Gionchetti P, Rizzello F. 1999. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 13:1103-1108 https://doi.org/10.1046/j.1365-2036.1999.00560.x
  63. Gionchetti P, Rizello F, Venturi A. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309 https://doi.org/10.1053/gast.2000.9370
  64. Sandborn WJ, McLeod R, Jewell DP. 1999. Medical therapy for induction and maintenance of remission in pouchitis: a systemic review. Inflammatory Bowel Diseases 5: 33-39 https://doi.org/10.1097/00054725-199902000-00005
  65. Meijer HP, Welters CF, Heineman E. 2000. Enteral inulin does not affect epithelial gene expression and cell turnover within the ileoanal pouch. Dis Colon Rectum 43: 1427-34 https://doi.org/10.1007/BF02236640
  66. Bhatia SJ, Kochar N, Abraham P. 1989. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 27: 2328-2330
  67. Lorca GL, Wadstrm T, Fond de Valdez G, Ljungh Å. 2001. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Current Microbiology 42: 39-44 https://doi.org/10.1007/s002840010175
  68. Canducci F, Armuzzi A, Cremonini F. 2000. A lyophilised and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14: 1625-1629 https://doi.org/10.1046/j.1365-2036.2000.00885.x
  69. Armuzzi A, Cremonini F, Ojetti V. 2001. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 63: 1-7
  70. Armuzzi A, Cremonini F, Bartolozzi F. 2001. The effect of oral administration of Lactobacillus GG on associated gastrointestinal side effects during Helicobacter eradication. Aliment Pharmacol Ther 15: 163-169 https://doi.org/10.1046/j.1365-2036.2001.00923.x
  71. Michetti P, Dorta G, Wiesel PH. 1999. Effect of whey based culture supernatant of Lactobacillus acidophilus (jonsonii) La1 on Helicobacter pylori infections in humans. Digestion 60: 203-209 https://doi.org/10.1159/000007660
  72. Swartz NN. 1994. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci 91: 2420- 2427 https://doi.org/10.1073/pnas.91.7.2420
  73. Isenmann R, Bchler MW. 1994. Infection and acute pancreatitis. Brit J Surg 81: 1707-1708 https://doi.org/10.1002/bjs.1800811203
  74. Brawley RL, Weber DJ, Samsa GP. 1989. Multiple nosocomial infections; an incidcence study. Am J Epidemiol 130: 769-780 https://doi.org/10.1093/oxfordjournals.aje.a115398
  75. Weber DJ, Raasch R, Rutala WA. 1999. Nosocomial infections in the ICU; the growing importance of antibiotic-resistant pathogens. Chest 115: 34S-41S https://doi.org/10.1378/chest.115.suppl_1.34S
  76. Vincent JL, Bihari DJ, Suter DM. 1993. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 274: 639-644 https://doi.org/10.1001/jama.274.8.639
  77. Weinstein RA. 1991. Epidemiology and control of nosocomial infection in adult ICU. Am J Med 91 suppl: 179-184 https://doi.org/10.1016/0002-9343(91)90012-M
  78. Gomersall CM. 1998. Does the administration of lactobacillus to critically ill patients decrease the severity of multi- organ dysfunction or failure. Thesis for B Sc degree in Health Studies at University of Surrey, Roehampton Institute, School of Life Sciences, London
  79. Beger HG, Bittner R, Bchler M. 1986. Bacterial contamination of pancreatic necrosis--a prospective clinical study. Gastroenterology 91: 433-438 https://doi.org/10.1016/0016-5085(86)90579-2
  80. Bchler MW, Gloor B, Mller CA. 2000. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232: 619-626 https://doi.org/10.1097/00000658-200011000-00001
  81. Luiten EJT, Hop WCJ, Endtz HP, Bruining HA. 1998. Prognostic importance of gram-negative intestinal colonization pancreatic infection in severe acute pancreatitis. Intensive Care Med 24: 438-445 https://doi.org/10.1007/s001340050593
  82. Olh A, Belgyi T, Issekutz Á. Early enteral nutrition with specific Lactobacillus and fibre reduces sepsis in severe acute pancreatitis. Submitted for publication
  83. Rayes N, Hansen S, Boucsein K. Comparison of parenteral and early enteral nutrition with fibre and lactobacilli after major abdominal surgery a prospective randomized trial. Submitted for publication
  84. Rayes N, Hansen S, Boucsein K. 2001. Early enteral supply of Lactobacillus and fibre vs selective bowel decontamination (SBD)--a controlled trial in liver transplant recipients. Submitted for publication
  85. Rice-Evans CA, Miller NJ. 1996. Antioxidant activities of flavonoids as bioactive components of food. Biochemical Society Transactions 24: 790-95 https://doi.org/10.1042/bst0240790
  86. Bengmark S. 2001. Nutritional modulation of acute and “chronic” phase response. Nutrition 17: 489-495 https://doi.org/10.1016/S0899-9007(01)00581-0
  87. Bengmark S. 2001. Immunomodulation by pro- and prebiotics. Biuoscience Microflora 20: 9-18 https://doi.org/10.12938/bifidus1996.20.9